GlassScriptPhysician profile
Apurva Trivedi
NPI 1871771857
$9,155.06
in general payments reported to CMS, 2019-2025
25 companies · $34.13 in 2025
The $34.13 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,607 · 2020: $5,071 · 2021: $726 · 2022: $550 · 2023: $167 · 2025: $34.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $200.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $6,133.13 | 2019-2020 | |
| Abbvie INC. | $737.01 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $347.23 | 2021-2023 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $337.80 | 2019-2021 | |
| Gilead Sciences, INC. | $256.34 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $245.10 | 2019-2022 | |
| Axonics, INC. | $211.53 | 2020-2021 | |
| Allergan, INC. | $128.72 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $112.43 | 2019-2022 | |
| Janssen Biotech, INC. | $101.40 | 2019-2021 | |
| Celgene Corporation | $100.82 | 2021-2022 | |
| Pfizer INC. | $97.17 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $50.59 | 2019 | |
| Daiichi Sankyo INC. | $41.36 | 2019 | |
| Ucb, INC. | $38.43 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $34.13 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $33.89 | 2022 | |
| Nestle Healthcare Nutrition INC. | $32.04 | 2021 | |
| Ironwood Pharmaceuticals, INC | $27.19 | 2019-2020 | |
| Ethicon US, LLC | $16.71 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.10 | 2022 | |
| Olympus America INC. | $15.40 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $14.87 | 2022 | |
| Qol Medical, LLC | $13.03 | 2021 | |
| Enterra Medical, INC. | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apurva Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.